Chemo Pharma Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 0.02 | -0.16 | -0.15 |
| Operating Expense | 11.83 | 0.02 | 0.02 |
| Net Profit | -11.81 | -0.34 | -0.17 |
| Net Profit Margin | -59,050 | 212.50 | 113.33 |
| Earning Per Share | -78.70 | -2.26 | -1.17 |
| EBIDTA | -11.81 | -0.14 | -0.17 |
| Effective Tax Rate | TBA | -111.11 | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 0.02 |
| Operating Expense | 11.83 |
| Net Profit | -11.81 |
| Net Profit Margin | -59050.00 |
| Earning Per Share | -78.70 |
| EBIDTA | -11.81 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | TBA | TBA | TBA |
| Operating Expenses Annual | 0.12 | 0.19 | 0.21 |
| Operating Profit Annual | 0.50 | 1.65 | 0.09 |
| Interest Annual | TBA | TBA | TBA |
| Depreciation | 0.01 | 0.01 | 0.01 |
| Net Profit Annual | 0.34 | 1.20 | 0.05 |
| Tax Annual | 0.16 | 0.44 | 0.03 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | TBA |
| Operating Expenses Annual | 0.12 |
| Operating Profit Annual | 0.50 |
| Interest Annual | TBA |
| Depreciation | 0.01 |
| Net Profit Annual | 0.34 |
| Tax Annual | 0.16 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.61 | 0.56 | 0.69 |
| Cash Flow from Operations | -0.28 | 0.72 | -0.68 |
| Cash Flow from Investing | 10.46 | -0.52 | 0.63 |
| Cash Flow from Financing | -0.16 | -0.15 | -0.08 |
| Cash Flow at the End | 10.62 | 0.61 | 0.56 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.61 |
| Cash Flow from Operations | -0.28 |
| Cash Flow from Investing | 10.46 |
| Cash Flow from Financing | -0.16 |
| Cash Flow at the End | 10.62 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | TBA | TBA | TBA |
| PBIT Margin (%) | TBA | TBA | TBA |
| PBT Margin (%) | TBA | TBA | TBA |
| Net PROFIT Margin (%) | TBA | TBA | TBA |
| Return On Networth / Equity (%) | 3.47 | 9.84 | 0.43 |
| Return On Networth /Employed (%) | 5.24 | 13.44 | 0.78 |
| Return On Assets (%) | TBA | TBA | TBA |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | TBA |
| PBIT Margin (%) | TBA |
| PBT Margin (%) | TBA |
| Net PROFIT Margin (%) | TBA |
| Return On Networth / Equity (%) | 3.47 |
| Return On Networth /Employed (%) | 5.24 |
| Return On Assets (%) | TBA |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 0.01 | 0.02 | 0.03 |
| Total Current Assets Annual | 10.81 | 6.25 | 6.13 |
| Non Current Assets Annual | 2.54 | 6.76 | 5.49 |
| Total Shareholders Funds Annual | 13.14 | 12.80 | 11.60 |
| Total Assets Annual | 13.35 | 13.02 | 11.62 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 0.01 |
| Total Current Assets Annual | 10.81 |
| Non Current Assets Annual | 2.54 |
| Total Shareholders Funds Annual | 13.14 |
| Total Assets Annual | 13.35 |
No Data Availabe
